Interactions of marine sulfated glycans with antithrombin and platelet factor 4.
antithrombin
carbohydrate-protein interactions
heparin
platelet factor 4
sulfated glycans
surface plasmon resonance
Journal
Frontiers in molecular biosciences
ISSN: 2296-889X
Titre abrégé: Front Mol Biosci
Pays: Switzerland
ID NLM: 101653173
Informations de publication
Date de publication:
2022
2022
Historique:
received:
27
05
2022
accepted:
05
09
2022
entrez:
6
10
2022
pubmed:
7
10
2022
medline:
7
10
2022
Statut:
epublish
Résumé
The molecular interactions of sulfated glycans, such as heparin, with antithrombin (AT) and platelet factor 4 (PF4) are essential for certain biological events such as anticoagulation and heparin induced thrombocytopenia (HIT). In this study, a library including 84 sulfated glycans (polymers and oligomers) extracted from marine algae along with several animal-originated polysaccharides were subjected to a structure-activity relationship (SAR) study regarding their specific molecular interactions with AT and PF4 using surface plasmon resonance. In this SAR study, multiple characteristics were considered including different algal species, different methods of extraction, molecular weight, monosaccharide composition, sulfate content and pattern and branching vs. linear chains. These factors were found to influence the binding affinity of the studied glycans with AT. Many polysaccharides showed stronger binding than the low molecular weight heparin (e.g., enoxaparin). Fourteen polysaccharides with strong AT-binding affinities were selected to further investigate their binding affinity with PF4. Eleven of these polysaccharides showed strong binding to PF4. It was observed that the types of monosaccharides, molecular weight and branching are not very essential particularly when these polysaccharides are oversulfated. The sulfation levels and sulfation patterns are, on the other hand, the primary contribution to strong AT and PF4 interaction.
Identifiants
pubmed: 36200072
doi: 10.3389/fmolb.2022.954752
pii: 954752
pmc: PMC9527323
doi:
Types de publication
Journal Article
Langues
eng
Pagination
954752Subventions
Organisme : NIGMS NIH HHS
ID : P20 GM130460
Pays : United States
Organisme : NINDS NIH HHS
ID : R03 NS110996
Pays : United States
Informations de copyright
Copyright © 2022 Zhang, Jin, Pomin, Zhang and Linhardt.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
J Biol Chem. 1982 Jan 10;257(1):400-6
pubmed: 7053378
Molecules. 2019 Aug 01;24(15):
pubmed: 31374852
Hemodial Int. 2001 Jan;5(1):74-80
pubmed: 28452441
Glycoconj J. 2014 Jul;31(5):341-4
pubmed: 24838988
Int J Biol Macromol. 2017 Dec;105(Pt 1):686-692
pubmed: 28716753
Carbohydr Polym. 2020 Nov 15;248:116785
pubmed: 32919573
Molecules. 2019 Sep 16;24(18):
pubmed: 31527407
J Pharm Sci. 2020 Feb;109(2):975-980
pubmed: 31705871
Int J Biol Macromol. 2010 Jan 1;46(1):6-12
pubmed: 19883681
Pharmaceuticals (Basel). 2015 Dec 10;8(4):848-64
pubmed: 26690451
Biochim Biophys Acta. 2013 Apr;1830(4):3054-66
pubmed: 23313164
Int J Biol Macromol. 2020 Oct 1;160:26-34
pubmed: 32464202
Mar Drugs. 2018 Aug 30;16(9):
pubmed: 30200211
Biochem Physiol. 2018;7(2):
pubmed: 30271699
Chemistry. 2020 Sep 10;26(51):11814-11818
pubmed: 32515841
Thromb Haemost. 1997 Jul;78(1):516-9
pubmed: 9198206
Mar Drugs. 2019 Jan 11;17(1):
pubmed: 30641954
Carbohydr Polym. 2015 May 5;121:207-16
pubmed: 25659691
Mar Drugs. 2015 Dec 25;14(1):3
pubmed: 26712768
J Thromb Haemost. 2020 Dec;18(12):3142-3153
pubmed: 32780936
Biochimie. 2010 Nov;92(11):1587-96
pubmed: 20685328
Biochim Biophys Acta. 2012 Dec;1820(12):1971-9
pubmed: 22964140
Front Cell Infect Microbiol. 2014 Jan 29;4:5
pubmed: 24524028
Int J Biol Macromol. 2020 Apr 15;149:450-458
pubmed: 32004605
Glycobiology. 2005 Apr;15(4):369-81
pubmed: 15590773
J Biol Chem. 1998 Mar 27;273(13):7478-87
pubmed: 9516447
Carbohydr Polym. 2015 Nov 5;132:118-25
pubmed: 26256332
Mar Drugs. 2012 Oct;10(10):2138-2152
pubmed: 23170074
Nat Prod Rep. 2009 Mar;26(3):313-21
pubmed: 19240943
Front Cell Infect Microbiol. 2014 Mar 06;4:33
pubmed: 24639954
Carbohydr Polym. 2012 Oct 1;90(2):993-1002
pubmed: 22840031
Protein Expr Purif. 2018 Nov;151:23-29
pubmed: 29894802
Arch Biochem Biophys. 1985 Jul;240(1):446-55
pubmed: 2409923
Mar Drugs. 2018 Aug 21;16(9):
pubmed: 30134603
Int J Biol Macromol. 2020 Nov 15;163:776-787
pubmed: 32653371
Carbohydr Polym. 2013 Aug 14;97(1):116-20
pubmed: 23769525
Carbohydr Polym. 2017 Nov 1;175:395-408
pubmed: 28917882